But heres what really matters if youre dealing with type 2 diabetes (T2D) The REDEFINE 2 trial showed CagriSema achieving 13.7% weight loss vs 3.4% with placebo at 68 weeks in T2D patients
Contact us today to schedule your initial consultation and take the first step towards a healthier, happier future.
"Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology: Post Hoc Analysis of the STEP 1, 2, 3, and 5 Trials." JAMA Internal Medicine, 3 Sept
They also improve metabolic balance by regulating glucose homeostasis and increasing insulin sensitivity in peripheral tissues 37
Because Mounjaro works by slowing down your digestive process, it can significantly worsen symptoms for those whose digestion is already delayed
On July 23, 2026, Lilly announced positive topline results from two additional Phase 3 trials, TRIUMPH-2 and TRIUMPH-3